Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Rxsight Inc (NQ: RXST )

50.66 +1.05 (+2.12%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 16, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 228,745
Open 49.85
Bid (Size) 48.92 (1)
Ask (Size) 53.73 (1)
Prev. Close 49.61
Today's Range 49.59 - 50.86
52wk Range 20.66 - 66.54
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Peeling Back The Layers: Exploring RxSight Through Analyst Insights
Via Benzinga
RxSight, Inc. to Participate in Upcoming Morgan Stanley and Wells Fargo Healthcare Conferences
From RxSight, Inc.
Via GlobeNewswire

Performance

YTD
+38.23%
+38.23%
1 Month
-8.79%
-8.79%
3 Month
+2.49%
+2.49%
6 Month
-6.72%
-6.72%
1 Year
+98.90%
+98.90%

More News

Read More
RxSight Stock Sees Relative Strength Rating Rise To 91
Via Investor's Business Daily
Deep Dive Into RxSight Stock: Analyst Perspectives (6 Ratings)
Via Benzinga
Lithia Motors To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga
RxSight Analysts Slash Their Forecasts After Q2 Results
Via Benzinga
RXST Stock Earnings: RxSight Beats Revenue for Q2 2024
Via InvestorPlace
RxSight Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
Why Palantir Technologies Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket
Via Benzinga
RxSight, Inc. Reports Second Quarter 2024 Financial Results
From RxSight, Inc.
Via GlobeNewswire
Why RxSight (RXST) Shares Are Falling
Via Benzinga
What 10 Analyst Ratings Have To Say About RxSight
Via Benzinga
The 3 Best Med Tech Stocks to Buy Now
Via InvestorPlace
RxSight, Inc. to Report Second Quarter Financial Results on August 5, 2024
From RxSight, Inc.
Via GlobeNewswire
Johnson & Johnson Q2 Earnings Preview: Can New Drugs Lift Sagging Stock?
Via Benzinga
Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
RxSight, Inc. To Participate in the Truist Securities Medtech Conference
From RxSight, Inc.
Via GlobeNewswire
Do You Have Your Eye On Vision Care Stocks?
Via Talk Markets
RxSight, Inc. Announces Closing of its Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. Announces Pricing of Public Offering of Common Stock
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. Announces Proposed Public Offering of Common Stock
From RxSight, Inc.
Via GlobeNewswire
RXST Stock Earnings: RxSight Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
RxSight, Inc. Reports First Quarter 2024 Financial Results
From RxSight, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.